EXELIXIS, INC.

Company Profile

Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.

Employees

954

Headquarters

ALAMEDA, CA, United States

Website

www.exelixis.com